PVG Asset Management’s Orchard Therapeutics plc American Depositary Shares ORTX Stock Holding History

PVG Asset Management’s Portfolio ORTX Stock Details ORTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	$13.2K	Buy	+1,000	New	+$16.5K	0.05%	49

Other funds holding ORTX

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

PIM

Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

PVG Asset Management's ORTX Position: Q4 2021 in Review

PVG Asset Management opened a new position in Orchard Therapeutics plc American Depositary Shares (ORTX) in Q4 2021: 1,000 shares worth $13.2K. The stake represents 0.05% of the portfolio and ranks #49 among its holdings.

72 funds tracked by Wall St. Rank hold ORTX as of Q4 2021.

PVG Asset Management held 1,000 shares of Orchard Therapeutics plc American Depositary Shares worth $13.2K as of Q4 2021.
Orchard Therapeutics plc American Depositary Shares was a new PVG Asset Management position in Q4 2021.
Orchard Therapeutics plc American Depositary Shares made up 0.05% of PVG Asset Management's portfolio in Q4 2021, its #49 holding.
72 funds tracked by Wall St. Rank held Orchard Therapeutics plc American Depositary Shares as of Q4 2021.

Based on PVG Asset Management's 13F filing for Q4 2021, filed 2 Feb 2022.